[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"behavior-hyperactive\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:behavior-hyperactive":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":30,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":39,"lastUpdatePostDateStruct":40,"startDateStruct":43,"completionDateStruct":45,"leadSponsor":47,"locationsCount":50},"100533930","attention-deficit-hyperactivity-disorder-100533930",false,"NCT06232226","Attention Deficit Hyperactivity Disorder","Addictions and Attention Deficit Disorder With or Without Hyperactivity","ADA","Inclusion Criteria :\n\n* Patients aged over 18 years\n* For whom a diagnosis of ADHD has been confirmed less than 12 weeks ago\n* For whom the diagnosis of one or more addictive disorder(s) (substance use disorder or behavioral addiction) has been confirmed\n* Meeting the indication for treatment with MPH according to European recommendations (Kooij et al., 2019)\n* For patients who can actually benefit from MPH: who have not yet started taking MPH\n* Social security affiliates\n\nExclusion Criteria :\n\n* Presenting disorders of higher cognitive functions (at the discretion of the referring clinician or the investigator making the inclusion), making data collection impossible\n* Presenting difficulties in reading or writing the French language making data collection impossible\n* Unable to commit to being available for the 2 visits planned as part of the cohort\n* Under guardianship or legal protection\n* Patients who have used psychoactive substances within 12 hours prior to their visit","ALL","18 Years","99 Years",{"count":21,"type":22},80,"ESTIMATED","INTERVENTIONAL",[25],"NA","The ADA cohort aims for the systematic and standardized collection of sociodemographic, clinical and neuropsychological data, during 2 visits (inclusion and 12 months), from patients suffering from the co-occurrence of ADHD (Attention Deficit Hyperactivity Disorder) and addiction(s), in addition to the treatment as usual adapted to each situation.",[13,28,29],"Behavior Hyperactive","Behavior Disorders",[31,32,33,34,35,36,37],"Attention Deficit Disorder with Hyperactivity","Addictive disorders","Neuropsychology","Methylphenidate","Atomoxetine","Functional impairment","Symptoms","RECRUITING","2026-04-14",{"date":41,"type":42},"2026-04-17","ACTUAL",{"date":44,"type":42},"2024-04-11",{"date":46,"type":22},"2026-12-31",{"name":48,"class":49},"Nantes University Hospital","OTHER",3]